EUR 25.05
(0.2%)
Year | Net Debt | Net Debt Growth |
---|---|---|
2023 | 332.59 Million EUR | 23.02% |
2022 | 270.35 Million EUR | 24.13% |
2021 | 217.81 Million EUR | -15.11% |
2020 | 256.58 Million EUR | -13.46% |
2019 | 296.48 Million EUR | -3.94% |
2018 | 308.65 Million EUR | 10.87% |
2017 | 278.4 Million EUR | -7.76% |
2016 | 301.84 Million EUR | 4.87% |
2015 | 287.83 Million EUR | 373.35% |
2014 | 60.8 Million EUR | -26.28% |
2013 | 82.48 Million EUR | -16.69% |
2012 | 99 Million EUR | 1357.74% |
2011 | -7.87 Million EUR | 14.53% |
2010 | -9.21 Million EUR | -4.11% |
2009 | -8.84 Million EUR | 35.83% |
2008 | -13.78 Million EUR | -39.44% |
2007 | -9.88 Million EUR | -115.95% |
2006 | 61.98 Million EUR | 74.06% |
2005 | 35.6 Million EUR | -9.34% |
2004 | 39.27 Million EUR | 0.0% |
Year | Net Debt | Net Debt Growth |
---|---|---|
2024 Q2 | 342.01 Million EUR | 0.0% |
2023 Q4 | 332.59 Million EUR | 0.0% |
2023 FY | 332.59 Million EUR | 23.02% |
2023 Q2 | 342.34 Million EUR | 0.0% |
2022 Q2 | 251.48 Million EUR | 0.0% |
2022 Q4 | 270.35 Million EUR | 0.0% |
2022 FY | 270.35 Million EUR | 24.13% |
2021 FY | 217.81 Million EUR | -15.11% |
2021 Q2 | 249.34 Million EUR | 0.0% |
2021 Q4 | 217.81 Million EUR | 0.0% |
2020 Q4 | 256.58 Million EUR | 0.0% |
2020 Q2 | 269.31 Million EUR | 0.0% |
2020 FY | 256.58 Million EUR | -13.46% |
2019 Q4 | 296.48 Million EUR | 0.0% |
2019 FY | 296.48 Million EUR | -3.94% |
2019 Q2 | 358.05 Million EUR | 0.0% |
2018 Q4 | 308.65 Million EUR | 0.0% |
2018 FY | 308.65 Million EUR | 10.87% |
2018 Q2 | 328.99 Million EUR | 0.0% |
2017 Q2 | 310.67 Million EUR | 0.0% |
2017 FY | 278.4 Million EUR | -7.76% |
2017 Q4 | 278.4 Million EUR | 0.0% |
2016 Q2 | 297.55 Million EUR | 0.0% |
2016 FY | 301.84 Million EUR | 4.87% |
2016 Q4 | 301.84 Million EUR | 0.0% |
2015 FY | 287.83 Million EUR | 373.35% |
2015 Q4 | 287.83 Million EUR | 0.0% |
2015 Q2 | 53.41 Million EUR | 0.0% |
2014 Q2 | 83.28 Million EUR | 0.0% |
2014 Q4 | 60.8 Million EUR | 0.0% |
2014 FY | 60.8 Million EUR | -26.28% |
2013 Q4 | 82.48 Million EUR | 0.0% |
2013 Q2 | 96.61 Million EUR | 0.0% |
2013 FY | 82.48 Million EUR | -16.69% |
2012 Q2 | -4.71 Million EUR | 0.0% |
2012 FY | 99 Million EUR | 1357.74% |
2012 Q4 | 99 Million EUR | 0.0% |
2011 Q4 | -7.87 Million EUR | 0.0% |
2011 Q2 | -11.2 Million EUR | 0.0% |
2011 FY | -7.87 Million EUR | 14.53% |
2010 FY | -9.21 Million EUR | -4.11% |
2010 Q2 | -10.11 Million EUR | 0.0% |
2010 Q4 | -9.21 Million EUR | 0.0% |
2009 FY | -8.84 Million EUR | 35.83% |
2009 Q4 | -8.84 Million EUR | 0.0% |
2008 FY | -13.78 Million EUR | -39.44% |
2007 FY | -9.88 Million EUR | -115.95% |
2006 FY | 61.98 Million EUR | 74.06% |
2005 FY | 35.6 Million EUR | -9.34% |
2004 FY | 39.27 Million EUR | 0.0% |
Name | Net Debt | Net Debt Difference |
---|---|---|
Affluent Medical SA | 15.47 Million EUR | -2049.082% |
Bluelinea Société Anonyme | -870.82 Thousand EUR | 38292.661% |
Carmat SA | 49.63 Million EUR | -570.062% |
Diagnostic Medical Systems S.A. | 11.52 Million EUR | -2785.08% |
Euromedis Groupe | -8.82 Million EUR | 3868.258% |
Eurobio Scientific Société anonyme | 51.33 Million EUR | -547.911% |
Ikonisys S.A. | 3.19 Million EUR | -10299.678% |
Implanet S.A. | 5.9 Million EUR | -5534.288% |
Median Technologies SA | 3.5 Million EUR | -9386.366% |
SpineGuard SA | 215.79 Thousand EUR | -154022.625% |
Theraclion SA | -5.86 Million EUR | 5771.242% |
Euroapi S.A. | 191 Million EUR | -74.132% |
Ion Beam Applications SA | -67.72 Million EUR | 591.106% |
Koninklijke Philips N.V. | 5.82 Billion EUR | 94.285% |
Sequana Medical NV | 14.2 Million EUR | -2241.734% |